Skip to main content

Table 1 Detailed imaging parameters of the magnetic resonance imaging instruments used in the current investigation

From: Quantitative assessment of washout in hepatocellular carcinoma using MRI

Sonata®

Avanto®

Trio®

Skyra®

T2wa tra

T2wa tra

T2wa tra

T2wa tra

T1w in/opposed phase b tra

T1w in/opposed phase b tra

T1w in/opposed phase b tra

T1w in/opposed phase b tra

Diffusion-weighted imaging tra

Diffusion-weighted imaging tra

Diffusion-weighted imaging tra

Diffusion-weighted imaging tra

4x T1w fs (native, arterial, portal venous, equilibrium) c

4x T1w fs (native, arterial, portal venous, equilibrium) d

4x T1w fs (native, arterial, portal venous, equilibrium) d

4x T1w fs (native, arterial, portal venous, equilibrium) d

T1w b tra/cor (delayed)

T1w b tra (delayed)

T1w b tra (delayed)

T1w b tra (delayed)

  1. tra transversal, cor coronal
  2. a T2-weighted half-Fourier acquisition single-shot turbo spin-echo sequence (HASTE)
  3. b T1-weighted fat-suppressed fast low-angle shot gradient echo sequence (FLASH®)
  4. c T1-weighted fat-suppressed multi-phase contrast-enhanced series (FL 3d)
  5. d T1-weighted fat-suppressed multi-phase contrast-enhanced series (VIBE®)